Mitsuhiro Sugimoto

Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade

Yuki Takada‐Takatori, Toshiaki Kume, Mitsuhiro Sugimoto et al. · Neuropharmacology · 2006 · 184 citations

Alzheimer's Disease, Phosphatidylinositol 3-Kinase Cascade, Dementia +14

Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton’s jelly explants of human umbilical cord

Ikuo Ishige, Tokiko Nagamura‐Inoue, Masaki Honda et al. · International Journal of Hematology · 2009 · 171 citations

Tissue Engineering, Regenerative Medicine, Mesenchymal Stem Cells +13

Combined effects of maternal age and parity on successful initiation of exclusive breastfeeding

Naomi Kitano, Kyoko Nomura, Michiko Kido et al. · Preventive Medicine Reports · 2015 · 143 citations · Full text

Fertility, Reproductive Health, Gynecology +26

Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons

Toshiaki Kume, Mitsuhiro Sugimoto, Yuki Takada et al. · European Journal of Pharmacology · 2005 · 62 citations

Rat Cortical Neurons, Neurophysiology, Medicine +13

Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity

Yuki Takada‐Takatori, Toshiaki Kume, Mitsuhiro Sugimoto et al. · European Journal of Pharmacology · 2006 · 45 citations

Medicine, Neuropharmacology, Neuroprotection +3